METAVIA INC.

Profile

Company Names

METAVIA INC.
NEUROBO PHARMACEUTICALS, INC.
GEMPHIRE THERAPEUTICS INC.

Addresses

545 CONCORD AVENUE, SUITE 210, CAMBRIDGE, MA 02138

200 BERKELEY ST., FL 19, BOSTON, MA 02116

200 BERKELEY STREET, OFFICE 19TH FLOOR, BOSTON, MA 02116

17199 N. LAUREL PARK DRIVE, SUITE 401, LIVONIA, MI 48152

43334 7 MILE ROAD, SUITE 1000, NORTHVILLE, MI 48167

Phone Numbers

857-702-9600
(857) 702-9600
248-681-9815
7342554006

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$98,909,823.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2025-05-08 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
8
2024-06-23 
$16,998,224.00 
$16,998,224.00 
$0.00 
Equity 
7
2021-10-01 
$14,000,002.00 
$14,000,002.00 
$0.00 
Equity 
6
2021-01-21 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
5
2020-12-31 
$17,030,344.00 
$17,030,344.00 
$0.00 
Equity 
4
2017-03-15 
$12,540,704.00 
$12,540,704.00 
$0.00 
Equity 
3
2015-07-31 
$10,601,500.00 
$14,000,000.00 
$3,398,500.00 
Debt 
2
2015-03-31 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
1
2014-11-01 
$2,739,049.00 
$3,000,000.00 
$260,951.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
AKASH 
 
BAKSHI 
EXECUTIVE OFFICER, DIRECTOR
NEUROBO PHARMACEUTICALS, INC.
ANDREW 
 
BARTYNSKI 
EXECUTIVE OFFICER
NEUROBO PHARMACEUTICALS, INC.
CHARLES 
 
BISGAIER 
EXECUTIVE OFFICER, DIRECTOR
PRONAI THERAPEUTICS INC   |  HYGIEIA INC   |  GEMPHIRE THERAPEUTICS INC.
MARK 
A. 
GLICKMAN 
DIRECTOR
ARALEZ PHARMACEUTICALS INC.   |  NEUROBO PHARMACEUTICALS, INC.   |  METAVIA INC.
LEE 
S. 
GOLDEN 
EXECUTIVE OFFICER
GEMPHIRE THERAPEUTICS INC.   |  CADRENAL THERAPEUTICS, INC.
JASON 
 
GROVES 
DIRECTOR
NEUROBO PHARMACEUTICALS, INC.
JASON 
L. 
GROVES 
DIRECTOR
NEUROBO PHARMACEUTICALS, INC.   |  METAVIA INC.
STEVE 
 
GULLANS 
DIRECTOR
TETRAPHASE PHARMACEUTICALS INC   |  CLEVELAND HEARTLAB, INC.   |  PATHOGENETIX, INC.   |  GEMPHIRE THERAPEUTICS INC.
STEPHEN 
 
HAAKENSON 
DIRECTOR
GEMPHIRE THERAPEUTICS INC.
P. 
KENT 
HAWRYLUK 
DIRECTOR
AVIDITY NANOMEDICINES LLC   |  GEMPHIRE THERAPEUTICS INC.   |  AVIDITY BIOSCIENCES LLC
RICHARD 
J. 
KANG 
EXECUTIVE OFFICER, DIRECTOR
NEUROBO PHARMACEUTICALS, INC.
HYUNG 
HEON 
KIM 
DIRECTOR, EXECUTIVE OFFICER
NEUROBO PHARMACEUTICALS, INC.   |  METAVIA INC.
NA YEON 
 
KIM 
DIRECTOR
NEUROBO PHARMACEUTICALS, INC.
KENNETH 
 
KOUSKY 
DIRECTOR
GEMPHIRE THERAPEUTICS INC.   |  RETROSENSE THERAPEUTICS, LLC
ANDREW 
 
KOVEN 
DIRECTOR
NEUROBO PHARMACEUTICALS, INC.   |  METAVIA INC.
ANDREW 
I 
KOVEN 
DIRECTOR
NEUROBO PHARMACEUTICALS, INC.
PEDRO 
 
LICHTINGER 
DIRECTOR
VELCERA, INC.   |  BIOTIME INC   |  ASTERIAS BIOTHERAPEUTICS, INC.   |  GEMPHIRE THERAPEUTICS INC.   |  CHEMIOCARE INC.   |  STARTON THERAPEUTICS INC.
DAVID 
 
LOWENSCHUSS 
EXECUTIVE OFFICER, DIRECTOR
GEMPHIRE THERAPEUTICS INC.
NADJA 
 
MANNOWETZ 
EXECUTIVE OFFICER
NEUROBO PHARMACEUTICALS, INC.
JEFFREY 
 
MATHIESEN 
EXECUTIVE OFFICER
SUNSHINE HEART, INC.   |  GEMPHIRE THERAPEUTICS INC.   |  ENEURA, INC.
MARGARET 
 
MCSHANE 
EXECUTIVE OFFICER
GEMPHIRE THERAPEUTICS INC.
JEONG GYUN 
 
OH 
DIRECTOR
NEUROBO PHARMACEUTICALS, INC.
DANIELA 
 
ONICIU 
EXECUTIVE OFFICER
GEMPHIRE THERAPEUTICS INC.
SETH 
 
RENO 
EXECUTIVE OFFICER
GEMPHIRE THERAPEUTICS INC.
MICHAEL 
 
SALSBURY 
DIRECTOR
NEUROBO PHARMACEUTICALS, INC.   |  METAVIA INC.
ANDY 
 
SASSINE 
DIRECTOR
FREEDOM MEDITECH INC   |  FREEDOM MEDITECH, INC   |  GEMPHIRE THERAPEUTICS INC.
NICOLA 
 
SHANNON 
EXECUTIVE OFFICER
NEUROBO PHARMACEUTICALS, INC.
MINA 
 
SOOCH 
EXECUTIVE OFFICER, DIRECTOR
PRONAI THERAPEUTICS INC   |  SVELTE MEDICAL SYSTEMS INC   |  GEMPHIRE THERAPEUTICS INC.   |  OCUPHIRE PHARMA, INC.   |  BIOVIE INC.   |  OCUPHIRE PHARMA, INC.
D. 
GORDON 
STRICKLAND 
DIRECTOR
NEUROBO PHARMACEUTICALS, INC.   |  METAVIA INC.
DOUGLAS 
J. 
SWIRSKY 
DIRECTOR
GENVEC INC   |  FIBROCELL SCIENCE, INC.   |  CELLECTAR BIOSCIENCES, INC.   |  AAVANTIBIO, INC.   |  NEUROBO PHARMACEUTICALS, INC.
JAMES 
P. 
TURSI 
DIRECTOR
AGILE THERAPEUTICS INC   |  NEUROBO PHARMACEUTICALS, INC.   |  METAVIA INC.
MARSHALL 
H. 
WOODWORTH 
EXECUTIVE OFFICER
NEUROBO PHARMACEUTICALS, INC.   |  METAVIA INC.
AMY 
 
ZAREMBA RABOURN 
DIRECTOR
GEMPHIRE THERAPEUTICS INC.   |  OCUPHIRE PHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-05-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-05-08 
2024-07-01
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-06-23 
2021-10-18
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-10-01 
2021-02-01
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-01-21 
2021-01-12
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-12-31 
2017-03-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-03-15 
2016-04-27
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2015-07-31 
2016-03-10
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2015-07-31 
2015-12-22
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2015-07-31 
2015-08-07
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2015-07-31 
2015-08-07
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2015-07-31 
2015-04-15
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2015-03-31 
2015-04-08
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2014-11-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LADENBURG THALMANN + CO. INC.
000000505
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
000000375
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
H.C. WAINWRIGHT + CO., INC.
375
NONE
NONE
PIPER JAFFRAY + CO.
665
NONE
NONE
LIFESCI CAPITAL LLC
168404